Hottest Stocks (Over $10)	Hottest Stocks ($2-$10)	Biggest Losers (Over $10)	Biggest Losers ($2-$10)	Hottest Industries	Hottest Sectors	EPS / Sales Surprises
Enter Ticker Symbol:   Ticker Lookup Company Quote Company Profile Research Summary EPS Consensus Perspective Insider Transactions Price Performance

Enter any portion of the company’s name to find its corresponding ticker symbol:

Search for :

Zacks Company Profile for CapsoVision, Inc. (CV : NSDQ)

• Company Description    CapsoVision Inc. is a commercial-stage medical technology company which develops advanced imaging and artificial intelligence technologies which are deployed in its capsule endoscopy solutions. CapsoVision Inc. is based in SARATOGA, Calif. Number of Employees: 28

• Price / Volume Information    Yesterday's Closing Price: $6.64 Daily Weekly Monthly 20 Day Moving Average: 112,946 shares Shares Outstanding: 49.96 (millions) Market Capitalization: $331.76 (millions) Beta: 52 Week High: $15.37 52 Week Low: $3.43 Short Interest Ratio:   % Price Change % Price Change Relative to S&P 500 4 Week 15.08% 9.46% 12 Week 30.71% 20.83% Year To Date -37.89% -41.78%

• Address & Contact Information Street Address Phone / Fax Email Address Web URL 18805 COX AVENUE SUITE 250 - SARATOGA,CA 95070 USA ph: 408-624-1488 fax: - investors@capsovision.com https://capsovision.com

• General Corporate Information    Officers Kang-Huai (Johnny) Wang - Director; President and Chief Executive Officer Chen Lung Tsai - Chairman of the Board of Director David Garcia - Senior Vice President of Finance Hui Ying (Patty) Kuo - Director Julia Gouw - Director Peer Information CapsoVision, Inc. (HLIS) CapsoVision, Inc. (AZTA) CapsoVision, Inc. (APYI) CapsoVision, Inc. (RNVA) CapsoVision, Inc. (HMSY) CapsoVision, Inc. (LRSI) Industry / Sector / Ticker Info Analyst Coverage: No Industry Group: MEDICAL INFO SYS Sector: Medical CUSIP: 140935107 SIC: 3845 Fiscal Year Fiscal Year End: December Last Reported Quarter: 03/01/26 Next Expected EPS Date: 08/13/26 Share - Related Items Shares Outstanding: 49.96 Most Recent Split Date: (:1) Beta: Market Capitalization: $331.76 (millions)

• EPS Information     • Dividend Information Analyst Coverage: No Dividend Yield: 0.00% Current Fiscal Quarter EPS Consensus Estimate: $ Indicated Annual Dividend: $0.00 Current Fiscal Year EPS Consensus Estimate: $ Payout Ratio: Number of Estimates in the Fiscal Year Consensus: Change In Payout Ratio: Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00 Next EPS Report Date: 08/13/26

• Fundamental Ratios P/E Current FY Estimate: - Trailing 12 Months: - PEG Ratio: - Price Ratios Price/Book: 16.41 Price/Cash Flow: - Price / Sales: 24.46 EPS Growth vs. Year Ago Period: -% vs. Previous Quarter: -% Sales Growth vs. Year Ago Period: 0.32% vs. Previous Quarter: -28.74% ROE 03/31/26 - - 12/31/25 - - 09/30/25 - - ROA 03/31/26 - -136.03 12/31/25 - -189.73 09/30/25 - - Current Ratio 03/31/26 - 4.57 12/31/25 - 3.77 09/30/25 - 5.19 Quick Ratio 03/31/26 - 3.92 12/31/25 - 3.09 09/30/25 - 4.50 Operating Margin 03/31/26 - -198.87 12/31/25 - -186.77 09/30/25 - - Net Margin 03/31/26 - -198.87 12/31/25 - -186.77 09/30/25 - - Pre-Tax Margin 03/31/26 - -198.70 12/31/25 - -186.59 09/30/25 - - Book Value 03/31/26 - 0.40 12/31/25 - 0.28 09/30/25 - 0.44 Inventory Turnover 03/31/26 - 2.06 12/31/25 - 2.77 09/30/25 - - Debt-to-Equity 03/31/26 - 0.00 12/31/25 - 0.00 09/30/25 - 0.00 Debt-to-Capital 03/31/26 - 0.00 12/31/25 - 0.00 09/30/25 - 0.00

Powered by Zacks Investment Research ©